ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease

Table 2 Clinical characteristics in control subjects and patients with gallstones (mean ± SD)

Variable	Patients (n = 101)	Controls (n = 101)	P
Sex (F/M)	86.10%/13.90%	86.10%/13.90%	1.000
Age (yr)	51.93 ± 11.23	51.74 ± 10.99	0.904
Body mass index (kg/m2)	29.03 ± 4.19	27.63 ± 4.42	0.024
Serum glucose (mg/dL)	120.24 ± 44.20	100.30 ± 34.64	0.000
Lipids (mg/dL)	622.00 ± 149.77	688.60 ± 160.68	0.003
Cholesterol (mg/dL)	187.32 ± 45.10	208.21 ± 43.14	0.001
LDL cholesterol (mg/dL)	118.58 ± 41.64	130.94 ± 33.80	0.022
Triglycerides (mg/dL)	119.76 ± 87.05	144.45 ± 72.22	0.029
HDL cholesterol (mg/dL)	43.27 ± 13.26	46.56 ± 14.01	0.089
Cholesterol in stones (% by weight)	99.23 ± 2.50

LDL: Low density lipoprotein; HDL: High density lipoprotein.